Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Stephen Takacsy

<< Previous

Bullboard Posts

Next >>

Comment by retiredcfon Dec 12, 2017 7:41am

130 Views

Post# 27136110

RE:Stephen Takacsy

He was looking for it to get to $2.50. GLTA

https://www.bnn.ca/video/stephen-takacsy-s-past-picks~1282136

NAPEC (NPC.TO)

Recently received a takeover bid at $1.95 per share. We are expecting a higher offer from a strategic buyer such as one of their U.S. competitors, and so does the market.

• Then: $1.02

• Now: $1.99

• Return: 95.09%

• Total return: 95.09%

PAST TOP PICK

Napec Inc(NPC-T)

December 11, 2017

(A Top Pick Dec 12/16, Up 95%) They were acquiring companies in the US and are getting acquired themselves. The amount of work going on in the US for infrastructure repair is huge. It will be a 20 or 30 year run and so were attractive. He is hanging on for a better bid.

Chief Investment Officer & Portfolio Mgr, Lester Asset Managem...

Price $2.000

Owned Yes

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China